Hepar lobatum carcinomatosum

Authors

FC Deprez Department of Radiology, Cliniques Universitaires St-Luc, Catholic University of Louvain, Brussels, Belgium
E Coche Department of Radiology, Cliniques Universitaires St-Luc, Catholic University of Louvain, Brussels, Belgium
B Ghaye Department of Radiology, Cliniques Universitaires St-Luc, Catholic University of Louvain, Brussels, Belgium

DOI:

Keywords:

Lung neoplasms, secondary

Abstract

Background: A 59-year-old woman was admitted for rapid health degradation, with abdominal pain, icterus and ascites. She was known for a two years long-standing breast cancer aggravated progressively by multi-organ metastases. The patient was treated by hormonal therapy (Tamoxifen followed by Exemestane) and chemotherapy (5-Fluorouracil – Epirubucin – Cyclophosphamide then Cisplatine – 5-Fluorouracil).

Downloads

Published

2013-07-01

Issue

Vol. 96 No. 4 (2013)

Section

Original Article

License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms. If a submission is rejected or withdrawn prior to publication, all rights return to the author(s):

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

Submitting to the journal implicitly confirms that all named authors and rights holders have agreed to the above terms of publication. It is the submitting author's responsibility to ensure all authors and relevant institutional bodies have given their agreement at the point of submission.

Note: some institutions require authors to seek written approval in relation to the terms of publication. Should this be required, authors can request a separate licence agreement document from the editorial team (e.g. authors who are Crown employees).